Late complications of chemotherapy in testicular cancer

被引:22
|
作者
Pliarchopoulou, Kyriaki [1 ]
Pectasides, Dimitrios [1 ]
机构
[1] Univ Athens, Dept Internal Med 2, Propaedeut Oncol Sect, Attikon Univ Hosp, Athens, Greece
关键词
Germ-cell tumors; Toxicity; Long-term survivors; GERM-CELL TUMORS; LONG-TERM SURVIVORS; CORONARY-ARTERY DISEASE; COMBINATION CHEMOTHERAPY; RENAL-FUNCTION; RAYNAUDS-PHENOMENON; SECONDARY LEUKEMIA; FOLLOW-UP; 2ND CANCERS; CARDIOVASCULAR RISK;
D O I
10.1016/j.ctrv.2009.12.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cisplatin-based treatment has significantly increased survival in testicular cancer patients. Therefore, there has been enough interest for the late toxic effects of chemotherapy which affect the quality of life of the cancer survivors. These toxic effects may either persist or present long after the end of chemotherapy and involve the impairment of renal function, neurotoxicity, pulmonary toxicity and vascular disease. Also, a major issue experienced by a large number of patients is infertility, which has been improved due to modified surgical techniques, reduced treatment intensity, the use of sperm cryopreservation and methods of assisted reproduction. Physicians should also be aware of the risk of secondary malignancy development. Therefore, close follow-up of the testicular cancer survivors as well as, focus on minimizing treatment complications through improvement of treatment strategies are warranted. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:262 / 267
页数:6
相关论文
共 50 条
  • [1] Complications of surgery and chemotherapy for testicular cancer
    Abouassaly, R
    Klein, EA
    Raghavan, D
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2005, 23 (06) : 447 - 455
  • [2] Complications associated with chemotherapy in testicular cancer management
    Chunkit Fung
    David J. Vaughn
    Nature Reviews Urology, 2011, 8 : 213 - 222
  • [3] VASCULAR AND OTHER COMPLICATIONS OF CHEMOTHERAPY FOR TESTICULAR CANCER
    VOGELZANG, NJ
    WORLD JOURNAL OF UROLOGY, 1984, 2 (01) : 32 - 37
  • [4] Complications associated with chemotherapy in testicular cancer management
    Fung, Chunkit
    Vaughn, David J.
    NATURE REVIEWS UROLOGY, 2011, 8 (04) : 213 - 222
  • [5] LATE RELAPSE IN TESTICULAR CANCER AFTER CHEMOTHERAPY
    GEIER, LJ
    VOLK, SA
    WELDON, D
    REDMOND, J
    LANCET, 1983, 1 (8332): : 1049 - 1049
  • [6] Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer
    Berger, CC
    Bokemeyer, C
    Schneider, M
    Kuczyk, MA
    Schmoll, HJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) : 2229 - 2238
  • [7] Endocrinological late effects after chemotherapy for testicular cancer
    Berger, CC
    Bokemeyer, C
    Schuppert, F
    Schmoll, HJ
    BRITISH JOURNAL OF CANCER, 1996, 73 (09) : 1108 - 1114
  • [8] Endocrinologic late sequelae after chemotherapy for testicular cancer
    Berger, CC
    Bokemeyer, C
    Schuppert, F
    Schmoll, HJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 907 - 907
  • [9] NO EVIDENCE OF ACUTE CARDIOVASCULAR COMPLICATIONS OF CHEMOTHERAPY FOR TESTICULAR CANCER - AN ANALYSIS OF THE TESTICULAR-CANCER-INTERGROUP STUDY
    NICHOLS, CR
    ROTH, BJ
    WILLIAMS, SD
    GILL, I
    MUGGIA, FM
    STABLEIN, DM
    WEISS, RB
    EINHORN, LH
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (05) : 760 - 765
  • [10] Chemotherapy of testicular cancer
    Krege, S.
    Hartmann, J. T.
    Ruebben, H.
    UROLOGE, 2006, 45 (05): : 600 - 604